Department of Internal Medicine, Gastroenterology and Hepatology CCM
Projects
Artificial Nutrition
BPLG-005: Sustained release of human growth hormone in adult GHD
Covered TIPPS
cTIPS vs. optimized
Detection of GH-doping
Endoscopic Implantation of Enteryx® for GERD Treatment: A Randomized Sham-Controlled Multicenter Clinical Trial
EPA bei gastrointestinalen Tumoren
FIRM-ACT - First Internat. Randomized trial in locally advanced and Metastatic Adrenocortical Carcinoma Treatment
Genes involved in epithelial integrity..
GH-Doping: Development of a test method to detect GH abuse in sports
GOLD-Study Pegvisomant in diabetic nephropathy
Hepatische Enzephalopathie
Hormonal Regulation of Energy Metabolism, Body Weight and Growth. GRK 1208/1
HypoCCS: The Global Hypopituitary Control and Complications Study
Impact of oxidative stress on muscle function
Lanreotide and GH-antagonist in acromegalic patients
Mediatoren der Energiehomöost
Molecular basics of diseases in hepatology and gastroenterology
Muscelfunction and catabolic state
Nutzen einer poststationären Supplementa
Ökonomische Aspekte der Mangelernährung
Pegvisomant (MES03014/PEGA-0435-005; MES03013/PEGA-0435-003)
sPLA2 and lipoprotein metabolism
Wilson Disease (Eurocopper) C
If the list does not contain any entry, the request was executed without results